Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer
- PMID: 9520945
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer
Corrected and republished in
-
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.Lab Invest. 1998 Jun;78(6):i-xv. Lab Invest. 1998. PMID: 9645768
Abstract
Probasin (PB) gene product is prostate-specific, epithelial cell in origin, and androgen-regulated. A large 12-kb promoter fragment of the PB gene (LPB) was linked to the simian virus 40 (SV40) large T antigen (Tag) deletion mutant (that removes the expression of the small t antigen) to deliver consistently high levels of transgene expression to the transgenic mouse prostate. Seven male founders, their male offspring, and all the male offspring from two female founders developed at least prostatic epithelial cell hyperplasia by 10 weeks of age, indicating that the incidence of transformation was 100%. Tumorigenesis in the LPB-Tag animals progressed in a manner similar to that observed in the human prostate. Initially, multifocal proliferating lesions were detected in the prostatic epithelium, which continued to progress into hyperplasia involving the entire epithelium and then low-grade dysplasia. Reactive stromal proliferation was induced and continued to develop throughout the progression to high-grade dysplasia, carcinoma in situ, and adenocarcinoma. Immunohistochemical studies indicated that most stromal cells stained positively for both androgen receptor and smooth muscle alpha-actin, suggesting that stromal overgrowth largely represented mesenchymal cells that had differentiated into smooth muscle cells. Epithelial cell transformation was accompanied by the down-regulation of differentiated function, as suggested by the loss of dorsolateral prostate-specific secretory proteins. Tumor growth was regarded as androgen-dependent because tumors regressed in animals castrated at 11 weeks of age, and androgen treatment restored both epithelial/stromal cell ratio and tumor growth. Furthermore, small populations of prostatic epithelial cells in castrated animals continued to proliferate, suggesting the potential for androgen-independent growth. Although prostatic metastasis to other organs was not observed, local invasion was detected. In summary, the LPB-Tag animal model is unique in that it is the only model generated with the Tag alone, thereby eliminating any influences of the small t antigen on prostate tumor formation. Moreover, this model undergoes molecular changes similar to those found in human prostate including: (a) the multi-focal nature of tumorigenesis, (b) the progressive histopathologic changes from low- to high-grade dysplasia similar to human prostatic intraepithelial neoplasia, (c) stimulation of reactive stromal proliferation, and (d) the androgen-dependent growth of the primary tumor. Thus, the LPB-Tag prostate tumor model will be useful for studying the sequential mechanisms underlying the development of multistep tumorigenesis.
Similar articles
-
Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.Lab Invest. 1998 Jun;78(6):i-xv. Lab Invest. 1998. PMID: 9645768
-
A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.Cancer Res. 2001 Mar 1;61(5):2239-49. Cancer Res. 2001. PMID: 11280793
-
Transgenic mouse models for prostate cancer. Identification of an androgen-dependent promoter and creation and characterization of the long probasin promoter-Large T antigen (LPB-Tag) model.Methods Mol Med. 2003;81:113-47. doi: 10.1385/1-59259-372-0:113. Methods Mol Med. 2003. PMID: 12725118 No abstract available.
-
Human prostate cancer progression models and therapeutic intervention.Hinyokika Kiyo. 1997 Nov;43(11):815-20. Hinyokika Kiyo. 1997. PMID: 9436028 Review.
-
Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.J Cell Biochem. 2005 Feb 1;94(2):279-97. doi: 10.1002/jcb.20339. J Cell Biochem. 2005. PMID: 15565647 Review.
Cited by
-
p27kip1 protein levels reflect a nexus of oncogenic signaling during cell transformation.J Biol Chem. 2012 Jun 8;287(24):19775-85. doi: 10.1074/jbc.M112.361972. Epub 2012 Apr 17. J Biol Chem. 2012. PMID: 22511779 Free PMC article.
-
Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth.PLoS One. 2010 Sep 23;5(9):e12920. doi: 10.1371/journal.pone.0012920. PLoS One. 2010. PMID: 20886110 Free PMC article.
-
The genomic revolution and endocrine pathology.Endocr Pathol. 2008 Fall;19(3):139-47. doi: 10.1007/s12022-008-9042-2. Endocr Pathol. 2008. PMID: 18758692 Review.
-
Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status.J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):368-71. doi: 10.1016/j.jsbmb.2010.03.062. Epub 2010 Mar 27. J Steroid Biochem Mol Biol. 2010. PMID: 20347977 Free PMC article.
-
Models of neuroendocrine prostate cancer.Endocr Relat Cancer. 2015 Feb;22(1):R33-49. doi: 10.1530/ERC-14-0393. Epub 2014 Oct 27. Endocr Relat Cancer. 2015. PMID: 25349195 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical